2,6-Difluoroanisole | CAS:437-82-1

We serve 2,6-Difluoroanisole CAS:437-82-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,6-Difluoroanisole

Chemical Name:2,6-Difluoroanisole
CAS.NO:437-82-1
Synonyms:2,6-Difluoroanisole
1,3-Difluoro-2-methoxybenzene
Molecular Formula:C7H6F2O
Molecular Weight:144.11900
 
Physical and Chemical Properties:
Density:1.221
Boiling point:70-72ºC
Flash point:61ºC
Index of Refraction:1.452
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 2,6-Difluoroanisole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,3-Difluoro-2-methoxybenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,3-Difluoro-2-methoxybenzene Use and application,1,3-Difluoro-2-methoxybenzene technical grade,usp/ep/jp grade.


Related News: At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.2-Methoxyethyl chloride manufacturer At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.2-(1,3-dioxoisoindol-2-yl)acetaldehyde supplier It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.2-chloro-5-methylpyridin-3-amine vendor It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.For example, an active ingredient to relieve pain is included in a painkiller.